ZBH
42
-2
CI
48
-4
V
52
2
CMA
70
5
UNP
38
2
INTU
60
-3
A
43
-5
STI
18
11
AIV
37
-2
NWSA
64
-15
MUR
36
3
EOG
33
-3
XYL
33
6
CCL
81
16
GOOGL
47
4
CME
45
3
MCHP
47
-8
AEE
51
-7
PWR
56
3
AIG
77
2
ZBH
42
-2
CI
48
-4
V
52
2
CMA
70
5
UNP
38
2
INTU
60
-3
A
43
-5
STI
18
11
AIV
37
-2
NWSA
64
-15
MUR
36
3
EOG
33
-3
XYL
33
6
CCL
81
16
GOOGL
47
4
CME
45
3
MCHP
47
-8
AEE
51
-7
PWR
56
3
AIG
77
2
Financhill
Back

Guggenheim Strategic Opportunities Fund Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison

Buy
59

GOF
Guggenheim Strategic Opportunities Fund

Last Price:
$12.24
Seasonality Move:
0.55%
Buy
54

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:
$61.19
Seasonality Move:
5.52%
Buy
59
Guggenheim Strategic Opportunities Fund (GOF) is a Buy

Is Guggenheim Strategic Opportunities Fund a Buy, Sell or Hold?

  • The current Guggenheim Strategic Opportunities Fund [GOF] share price is $12.25. The Score for GOF is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • GOF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN) is a Buy

Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GOF Stock Price Chart

What is Guggenheim Strategic Opportunities Fund's stock price today?

  • The Guggenheim Strategic Opportunities Fund share price today is $12.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Stock Price Chart

What is BioMarin Pharmaceutical, Inc.'s stock price today?

  • The BioMarin Pharmaceutical, Inc. share price today is $61.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.

GOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 43.93 Sell
Chaikin Money Flow: 1752434 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.99 - 12.39) Buy
Bollinger Bands (100): (12.73 - 15.13) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 73.39 Buy
Chaikin Money Flow: 7836963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.19 - 56.01) Buy
Bollinger Bands (100): (52.65 - 57.43) Buy

GOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.14 Buy
20-day SMA: 12.18 Buy
50-day SMA: 12.89 Sell
200-day SMA: 14.39 Sell
8-day EMA: 12.15 Buy
20-day EMA: 12.26 Sell
50-day EMA: 12.85 Sell
200-day EMA: 14.13 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.6 Buy
20-day SMA: 54.21 Buy
50-day SMA: 53.61 Buy
200-day SMA: 57.94 Buy
8-day EMA: 54.44 Buy
20-day EMA: 53.99 Buy
50-day EMA: 54.1 Buy
200-day EMA: 58.28 Buy

Guggenheim Strategic Opportunities Fund Earnings Growth & GOF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.68 per share.

Guggenheim Strategic Opportunities Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioMarin Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):